Doctors do not consent to breast cancer surgery

Cancer cells divide rapidly chaotically and often grouped to form tumors.Removal of cancerous lymph nodes in some women with breast cancer has no benefit from scientists at the United States revealed in a new study.

And despite the fact that these revelations might have been acclaimed in some media as a revolutionary concept in the fight against breast cancer also left see major divisions between cancer specialists in the United Kingdom in the best way to treat the disease.

While some analysts expect that the study will result in a widespread practice for change - some medical units of the United Kingdom already have a less surgically aggressive approach-, others urge caution on the results.

The study, published in the Journal of the American Medical Association, are found among women with early stage breast cancer cancerous lymph node extraction practice no difference in survival rates.

Also concluded that the realization of the painful procedure - which can leave women with prolonged swelling rigidity arm and pain - has no difference as to whether cancer returned.

The study, which involved nearly 850 women examines the trend of recent years far from radical surgery in the fight against breast cancer.

Mastectomy (removal of the breast) rates are declining, but removing the nodes as a way to prevent the spread of cancer remained the standard procedure in the United States.

All participants in the trial, conducted between 1999 and 2004, had initial biopsies which showed that the cancer has spread to one or two neighbouring lymph nodes.

Women were randomized - to - be treated to remove 10 or more lymph nodes, or to none does not remove.

They were also treated with disappearances to eliminate tumors, a common form of radiation that covers the chest and armpit. Most received chemotherapy, hormonal therapy, or both.

The Group of researchers led by Dr. Armando Giuliano, Health Centre Saint-Jean in Santa Monica, California.

Professor Ian Ellis, specialist in pathology Oncology of the University of Nottingham, said the study was "very powerful" and that she had taken in "exemplary".

The study is very powerful. Place in an exemplary manner. There can be question. Changing practices

Dr Ian Ellis, specialist in oncologic pathology from the University of Nottingham

"No you can't question." "Should lead to changing practices," he says, but he acknowledged that medical units to the United Kingdom are very "polarized".

"It sometimes more than one Studio to change people's minds." In the United Kingdom doctors are a little conservative and want more evidence.

He said that about 15 years ago a 3000 women studying in Edinburgh and produce similar results, it was not to change practice in the United Kingdom, but this study claimed this medical unit and a few others.

"This shows that medical centers where a less aggressive treatment is practiced the right approach.

DRA. Rachel Greig, Director of Breast Cancer Charity policy breakthrough said the findings were "interesting", mainly because they corroborate the previous findings, but it is prudent speed with which practice may change.

He said "You can change the way some women are treated by the future breast cancer".

"This is important because it can mean that women can avoid unnecessary removal of lymph node surgery." "The results are based on previous research so that we look forward to developments in this important area."

Professor Michael Baum, a former breast surgeon and Director of clinical research at the University College London, said that having fun with the results of the investigation.

"What we are doing is to reinvent the wheel", told the BBC. "I've been preaching this for decades.

"We know 20 years or more, let in a lymph node treatment not containing a tumour does step endangers the survival over the long term."

He also said that the study will be influential in practice and patients would be advantageous.

In this context, Dr. Robert Mansel, Professor of surgery at the Faculty of medicine at the University of Wales and expert in breast cancer research said that it is a controversial with a vast amount and diversified practices "based on intuitions and not data."

Study has a tendency to pass radical surgery in the fight against cancer breast during the past years.

He also said that the five-year follow-up study is short.

"The breast if nothing else, is a disease long term what makes this study only reliable midway." We use the same tests, but the interpretation is different. "This is a classic problem in the treatment of cancer, we are not the answer.

Additional study "may change practice, but will take two or three years before we can definitively determine sobere form another."

View the original article here